Investors
SMSbiotech has discovered and named a new type of stem cell called the Small Mobile Stem cell, which is the core of its patented and proprietary technology.
SMSbiotech Brief Introduction
Introduction to 0ur Technology
What sets SMSbiotech apart from other biotech companies?
What is the Main Targeted Disease?
What are the Future Verticals?
What is the Therapeutic Pipeline?
What is Your Pathway to Revenue?
What is Your Regulatory Path?
Adoption of COPD Therapy:
What Are Current Relevant Markets?
What is the Goal of SMSbiotech as an Innovative Company?
Who are your Board Members?
Who can currently invest in SMSbiotech?
How does the company plan to use the proceeds from investments?
What are the company's plans for biomanufacturing?
How is SMSbiotech's intellectual property (IP) protected?
What are the opportunities at SMSbiotech for an investor exit
What are the primary risks associated with this investment, and how is the company mitigating them?
Disclaimer
Matters discussed in this website contain forward-looking statements. When used in this update, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with our history of losses and our need to raise additional financing, the acceptance of our products and technology in the marketplace, our ability to demonstrate the commercial viability of our products and technology and our need to increase the size of our organization. Further information on the Company's risk factors is contained in the Company's quarterly and annual reports as filed with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason except as may be required under applicable law.
Safe harbor statement
Matters discussed in this website contain forward-looking statements. When used in this update, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with our history of losses and our need to raise additional financing, the acceptance of our products and technology in the marketplace, our ability to demonstrate the commercial viability of our products and technology and our need to increase the size of our organization. Further information on the Company's risk factors is contained in the Company's quarterly and annual reports as filed with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update publicly any forward-looking statements for any reason except as may be required under applicable law.